Genmab A (GMAB) Receivables Refunds: 2020
- Genmab A's Receivables Refunds was N/A to $29.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $29.0 million, marking a year-over-year change of. This contributed to the annual value of $29.0 million for FY2020, which is N/A change from last year.
- Per Genmab A's latest filing, its Receivables Refunds stood at $29.0 million for Q4 2020.
- Genmab A's 5-year Receivables Refunds high stood at $29.0 million for Q4 2020, and its period low was $29.0 million during Q4 2020.
- Its 1-year average for Receivables Refunds is $29.0 million, with a median of $29.0 million in 2020.
